Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 308 entries
Sorted by: Best Match Show Resources per page
[Good clinical practices. Point of view of the university hospital].

La Revue de medecine interne

Bader JP.
PMID: 3809775
Rev Med Interne. 1986 Nov;11-3.

For clinical investigators, usually on the staff of university hospitals, the setting up in France of a good clinical practices system will no doubt improve the quality of clinical trials in that country. It remains that the investigator's responsibility...

Cite
Bader JP. Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire. [Good clinical practices. Point of view of the university hospital]. Rev Med Interne. 1986;11-3
Bader, J. P. (1986). Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire. [Good clinical practices. Point of view of the university hospital]. La Revue de medecine interne, 11-3.
Bader, J P. "Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire." [Good clinical practices. Point of view of the university hospital]. La Revue de medecine interne vol. (1986): 11-3.
Bader JP. Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire. [Good clinical practices. Point of view of the university hospital]. Rev Med Interne. 1986 Nov;11-3. French. PMID: 3809775.
Copy Download .nbib Format: NLM
The influence of host factors on drug response. VII. Implications for interpretation of clinical trials and other published studies on drug response in man.

Rational drug therapy

Vesell ES.
PMID: 7339701
Ration Drug Ther. 1981 Dec;15(12):1-5.

No abstract available.

Cite
Vesell ES. The influence of host factors on drug response. VII. Implications for interpretation of clinical trials and other published studies on drug response in man. Ration Drug Ther. 1981;15(12):1-5
Vesell, E. S. (1981). The influence of host factors on drug response. VII. Implications for interpretation of clinical trials and other published studies on drug response in man. Rational drug therapy, 15(12), 1-5.
Vesell, E S. "The influence of host factors on drug response. VII. Implications for interpretation of clinical trials and other published studies on drug response in man." Rational drug therapy vol. 15,12 (1981): 1-5.
Vesell ES. The influence of host factors on drug response. VII. Implications for interpretation of clinical trials and other published studies on drug response in man. Ration Drug Ther. 1981 Dec;15(12):1-5. PMID: 7339701.
Copy Download .nbib Format: NLM
Statistics and ethics in medical research.

British medical journal (Clinical research ed.)

Clarke MR.
PMID: 6780090
Br Med J (Clin Res Ed). 1981 Feb 07;282(6262):480. doi: 10.1136/bmj.282.6262.480-a.

No abstract available.

Cite
Clarke MR. Statistics and ethics in medical research. Br Med J (Clin Res Ed). 1981;282(6262):480doi: 10.1136/bmj.282.6262.480-a.
Clarke, M. R. (1981). Statistics and ethics in medical research. British medical journal (Clinical research ed.), 282(6262), 480. https://doi.org/10.1136/bmj.282.6262.480-a
Clarke, M R. "Statistics and ethics in medical research." British medical journal (Clinical research ed.) vol. 282,6262 (1981): 480. doi: https://doi.org/10.1136/bmj.282.6262.480-a
Clarke MR. Statistics and ethics in medical research. Br Med J (Clin Res Ed). 1981 Feb 07;282(6262):480. doi: 10.1136/bmj.282.6262.480-a. PMID: 6780090; PMCID: PMC1504204.
Copy Download .nbib Format: NLM
Good clinical research practice in Europe.

Journal of the Royal College of Physicians of London

Wells FO.
PMID: 1960690
J R Coll Physicians Lond. 1991 Oct;25(4):329.
Free PMC Article

No abstract available.

Cite
Wells FO. Good clinical research practice in Europe. J R Coll Physicians Lond. 1991;25(4):329
Wells, F. O. (1991). Good clinical research practice in Europe. Journal of the Royal College of Physicians of London, 25(4), 329.
Wells, F O. "Good clinical research practice in Europe." Journal of the Royal College of Physicians of London vol. 25,4 (1991): 329.
Wells FO. Good clinical research practice in Europe. J R Coll Physicians Lond. 1991 Oct;25(4):329. PMID: 1960690; PMCID: PMC5377155.
Copy Download .nbib Format: NLM
EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products.

Pharmacology & toxicology

[No authors listed]
PMID: 2077532
Pharmacol Toxicol. 1990 Oct;67(4):361-72. doi: 10.1111/j.1600-0773.1990.tb00847.x.

No abstract available.

Cite
EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products. Pharmacol Toxicol. 1990;67(4):361-72doi: 10.1111/j.1600-0773.1990.tb00847.x.
(1990). EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products. Pharmacology & toxicology, 67(4), 361-72. https://doi.org/10.1111/j.1600-0773.1990.tb00847.x
"EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products." Pharmacology & toxicology vol. 67,4 (1990): 361-72. doi: https://doi.org/10.1111/j.1600-0773.1990.tb00847.x
EEC note for guidance: good clinical practice for trials on medicinal products in the European Community. CPMP Working Party on Efficacy of Medicinal Products. Pharmacol Toxicol. 1990 Oct;67(4):361-72. doi: 10.1111/j.1600-0773.1990.tb00847.x. PMID: 2077532.
Copy Download .nbib Format: NLM
Plea for better protocols in clinical research.

Clinical and investigative medicine. Medecine clinique et experimentale

Genest J, Kuchel O.
PMID: 757509
Clin Invest Med. 1978;1(3):121-2.

No abstract available.

Cite
Genest J, Kuchel O. Plea for better protocols in clinical research. Clin Invest Med. 1978;1(3):121-2
Genest, J., & Kuchel, O. (1978). Plea for better protocols in clinical research. Clinical and investigative medicine. Medecine clinique et experimentale, 1(3), 121-2.
Genest, J, and Kuchel, O. "Plea for better protocols in clinical research." Clinical and investigative medicine. Medecine clinique et experimentale vol. 1,3 (1978): 121-2.
Genest J, Kuchel O. Plea for better protocols in clinical research. Clin Invest Med. 1978;1(3):121-2. PMID: 757509.
Copy Download .nbib Format: NLM
Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists.

PloS one

Kyte D, Ives J, Draper H, Keeley T, Calvert M.
PMID: 24124580
PLoS One. 2013 Oct 04;8(10):e76625. doi: 10.1371/journal.pone.0076625. eCollection 2013.

BACKGROUND: Patient-reported outcomes (PROs), such as health-related quality of life (HRQL) are increasingly used to evaluate treatment effectiveness in clinical trials, are valued by patients, and may inform important decisions in the clinical setting. It is of concern, therefore,...

Cite
Kyte D, Ives J, Draper H, et al. Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PLoS One. 2013;8(10):e76625doi: 10.1371/journal.pone.0076625.
Kyte, D., Ives, J., Draper, H., Keeley, T., & Calvert, M. (2013). Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PloS one, 8(10), e76625. https://doi.org/10.1371/journal.pone.0076625
Kyte, Derek, et al. "Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists." PloS one vol. 8,10 (2013): e76625. doi: https://doi.org/10.1371/journal.pone.0076625
Kyte D, Ives J, Draper H, Keeley T, Calvert M. Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists. PLoS One. 2013 Oct 04;8(10):e76625. doi: 10.1371/journal.pone.0076625. eCollection 2013. PMID: 24124580; PMCID: PMC3790726.
Copy Download .nbib Format: NLM
[Sample size and power analyses in clinical trials].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Pripp AH.
PMID: 28925211
Tidsskr Nor Laegeforen. 2017 Sep 18;137(17). doi: 10.4045/tidsskr.17.0414. Print 2017 Sep 19.

No abstract available.

Cite
Pripp AH. Antalls- og styrkeberegninger i medisinske studier. [Sample size and power analyses in clinical trials]. Tidsskr Nor Laegeforen. 2017;137(17)doi: 10.4045/tidsskr.17.0414.
Pripp, A. H. (2017). Antalls- og styrkeberegninger i medisinske studier. [Sample size and power analyses in clinical trials]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 137(17), . https://doi.org/10.4045/tidsskr.17.0414
Pripp, Are Hugo. "Antalls- og styrkeberegninger i medisinske studier." [Sample size and power analyses in clinical trials]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke vol. 137,17 (2017). doi: https://doi.org/10.4045/tidsskr.17.0414
Pripp AH. Antalls- og styrkeberegninger i medisinske studier. [Sample size and power analyses in clinical trials]. Tidsskr Nor Laegeforen. 2017 Sep 18;137(17). doi: 10.4045/tidsskr.17.0414. Print 2017 Sep 19. Norwegian. PMID: 28925211.
Copy Download .nbib Format: NLM
From the patient to the trial: networking for success.

The Lancet. Neurology

Morgan J.
PMID: 27302121
Lancet Neurol. 2016 May;15(6):549-50. doi: 10.1016/S1474-4422(16)30003-5. Epub 2016 Apr 11.

No abstract available.

Cite
Morgan J. From the patient to the trial: networking for success. Lancet Neurol. 2016;15(6):549-50doi: 10.1016/S1474-4422(16)30003-5.
Morgan, J. (2016). From the patient to the trial: networking for success. The Lancet. Neurology, 15(6), 549-50. https://doi.org/10.1016/S1474-4422(16)30003-5
Morgan, Jules. "From the patient to the trial: networking for success." The Lancet. Neurology vol. 15,6 (2016): 549-50. doi: https://doi.org/10.1016/S1474-4422(16)30003-5
Morgan J. From the patient to the trial: networking for success. Lancet Neurol. 2016 May;15(6):549-50. doi: 10.1016/S1474-4422(16)30003-5. Epub 2016 Apr 11. PMID: 27302121.
Copy Download .nbib Format: NLM
Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014.

BJU international

Schoenthaler M, Miernik A, Wilhelm K, Schlager D, Schoeb DS, Adams F, Dahm P, Hein S.
PMID: 26615772
BJU Int. 2016 May;117(5):787-92. doi: 10.1111/bju.13387. Epub 2015 Dec 29.

OBJECTIVES: To evaluate published trials on urolithiasis regarding level of evidence, type of sponsorship and declared conflicts of interest (COIs), and to elucidate a potential commercial impact.MATERIALS AND METHODS: We performed a systematic PubMed(®) literature search using a predefined...

Cite
Schoenthaler M, Miernik A, Wilhelm K, et al. Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int. 2015;117(5):787-92doi: 10.1111/bju.13387.
Schoenthaler, M., Miernik, A., Wilhelm, K., Schlager, D., Schoeb, D. S., Adams, F., Dahm, P., & Hein, S. (2016). Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU international, 117(5), 787-92. https://doi.org/10.1111/bju.13387
Schoenthaler, Martin, et al. "Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014." BJU international vol. 117,5 (2016): 787-92. doi: https://doi.org/10.1111/bju.13387
Schoenthaler M, Miernik A, Wilhelm K, Schlager D, Schoeb DS, Adams F, Dahm P, Hein S. Level of evidence, sponsorship, conflict of interest policy and commercial impact of PubMed-listed clinical urolithiasis-related trials in 2014. BJU Int. 2016 May;117(5):787-92. doi: 10.1111/bju.13387. Epub 2015 Dec 29. PMID: 26615772.
Copy Download .nbib Format: NLM
The quest for excellence (part 2): reviewing a clinical trial for the British Journal of Dermatology.

The British journal of dermatology

Ingram JR.
PMID: 25523245
Br J Dermatol. 2014 Dec;171(6):1277-8. doi: 10.1111/bjd.13445.

No abstract available.

Cite
Ingram JR. The quest for excellence (part 2): reviewing a clinical trial for the British Journal of Dermatology. Br J Dermatol. 2014;171(6):1277-8doi: 10.1111/bjd.13445.
Ingram, J. R. (2014). The quest for excellence (part 2): reviewing a clinical trial for the British Journal of Dermatology. The British journal of dermatology, 171(6), 1277-8. https://doi.org/10.1111/bjd.13445
Ingram, J R. "The quest for excellence (part 2): reviewing a clinical trial for the British Journal of Dermatology." The British journal of dermatology vol. 171,6 (2014): 1277-8. doi: https://doi.org/10.1111/bjd.13445
Ingram JR. The quest for excellence (part 2): reviewing a clinical trial for the British Journal of Dermatology. Br J Dermatol. 2014 Dec;171(6):1277-8. doi: 10.1111/bjd.13445. PMID: 25523245.
Copy Download .nbib Format: NLM
[Key factors in design of case report form].

Yao xue xue bao = Acta pharmaceutica Sinica

Fu HJ, Luo XX.
PMID: 26911041
Yao Xue Xue Bao. 2015 Nov;50(11):1452-5.

Case report form (CRF) is a key document for data collection in clinical trials. A well-designed CRF is required for database construction, data accuracy, data query/cleaning, CRF completion and statistical analysis. A well-defined process or SOP should be in...

Cite
Fu HJ, Luo XX. [Key factors in design of case report form]. Yao Xue Xue Bao. 2015;50(11):1452-5
Fu, H. J., & Luo, X. X. (2015). [Key factors in design of case report form]. Yao xue xue bao = Acta pharmaceutica Sinica, 50(11), 1452-5.
Fu, Hai-jun, and Luo, Xiao-xia. "[Key factors in design of case report form]." Yao xue xue bao = Acta pharmaceutica Sinica vol. 50,11 (2015): 1452-5.
Fu HJ, Luo XX. [Key factors in design of case report form]. Yao Xue Xue Bao. 2015 Nov;50(11):1452-5. Chinese. PMID: 26911041.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 308 entries